{"transactions":[{"id":914236,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-09T16:19:17.000Z","date":"2026-02-05","kind":"gift","planned":false,"acquired":true,"shares":145252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes.  This transfer is exempt from Section 16(b) by virtue of Rule 16b-5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":145252,"derivative":{"exercise_price":66.62,"expiration_date":"2035-12-15","underlying":"Class A Common Stock","underlying_shares":145252},"source":{"system":"sec-edgar","filing":"0001193125-26-042838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312526042838/ownership.xml","form_type":"4"}},{"id":914235,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-09T16:19:17.000Z","date":"2026-02-05","kind":"gift","planned":false,"acquired":false,"shares":145252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes.  This transfer is exempt from Section 16(b) by virtue of Rule 16b-5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":145252,"derivative":{"exercise_price":66.62,"expiration_date":"2035-12-15","underlying":"Class A Common Stock","underlying_shares":145252},"source":{"system":"sec-edgar","filing":"0001193125-26-042838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312526042838/ownership.xml","form_type":"4"}},{"id":964682,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":17633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 27,273 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 17,633 PSUs. The remaining 9,640 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 27,273 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 17,633 PSUs. The remaining 9,640 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":17633},"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964681,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-15","kind":"grant","planned":true,"acquired":true,"shares":145252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":145252,"derivative":{"exercise_price":66.62,"expiration_date":"2035-12-15","underlying":"Class A Common Stock","underlying_shares":145252},"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964680,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-15","kind":"grant","planned":true,"acquired":true,"shares":32984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":32984,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32984},"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964679,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":80,"price":67.54,"value":5403.2,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":98377,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964678,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":6671,"price":67.2351,"value":448525.3521,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The shares were sold in multiple transactions at prices ranging from $66.49 to $67.48, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":98457,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964677,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":4994,"price":67.1636,"value":335415.0184,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The shares were sold in multiple transactions at prices ranging from $67.00 to $67.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.  The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":105128,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964676,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":21772,"price":66.6404,"value":1450894.7888,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares were sold in multiple transactions at prices ranging from $65.98 to $66.975, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.  The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes 33,517 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":110122,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964675,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":6855,"price":66.62,"value":456680.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held following the reported transaction (i) include 143,784 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 6,751 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units."}],"balance_after":143784,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964674,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":27180,"price":67.54,"value":1835737.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transaction (i) include 157,390 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 18,017 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units."}],"balance_after":157390,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964673,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":17633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions (i) include 193,703 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 8,749 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of performance-based restricted stock units."}],"balance_after":202587,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":964672,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:43:02.000Z","date":"2025-12-15","kind":"grant","planned":true,"acquired":true,"shares":65968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 65,968 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 193,703 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":193703,"source":{"system":"sec-edgar","filing":"0001193125-25-323431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525323431/ownership.xml","form_type":"4"}},{"id":972491,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-11T17:04:48.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":false,"shares":23752,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":0,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":23752},"source":{"system":"sec-edgar","filing":"0001193125-25-316180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525316180/ownership.xml","form_type":"4"}},{"id":972490,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-11T17:04:48.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":false,"shares":10615,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":0,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":10615},"source":{"system":"sec-edgar","filing":"0001193125-25-316180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525316180/ownership.xml","form_type":"4"}},{"id":972489,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-11T17:04:48.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":6199,"price":67.5052,"value":418464.7348,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $67.39 to $67.60, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":98377,"source":{"system":"sec-edgar","filing":"0001193125-25-316180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525316180/ownership.xml","form_type":"4"}},{"id":972488,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-11T17:04:48.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":28168,"price":66.9919,"value":1887027.8392,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $66.38 to $67.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":104576,"source":{"system":"sec-edgar","filing":"0001193125-25-316180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525316180/ownership.xml","form_type":"4"}},{"id":972487,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-11T17:04:48.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":23752,"price":45.5,"value":1080716.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":132744,"source":{"system":"sec-edgar","filing":"0001193125-25-316180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525316180/ownership.xml","form_type":"4"}},{"id":972486,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-12-11T17:04:48.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":10615,"price":64.6,"value":685729.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":108992,"source":{"system":"sec-edgar","filing":"0001193125-25-316180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525316180/ownership.xml","form_type":"4"}},{"id":986751,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-11-26T20:37:25.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":11699,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":23752,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":11699},"source":{"system":"sec-edgar","filing":"0001193125-25-301000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525301000/ownership.xml","form_type":"4"}},{"id":986750,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-11-26T20:37:25.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":10615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-301000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525301000/ownership.xml","form_type":"4"}},{"id":986749,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-11-26T20:37:25.000Z","date":"2025-11-26","kind":"gift","planned":true,"acquired":false,"shares":16348,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 26, 2025, Mr. Yeaman gifted 16,348 shares of Class A Common Stock to a Donor-Advised Fund for the purpose of making charitable donations."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":98377,"source":{"system":"sec-edgar","filing":"0001193125-25-301000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525301000/ownership.xml","form_type":"4"}},{"id":986748,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-11-26T20:37:25.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":36699,"price":66.9066,"value":2455405.3134,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $66.53 to $67.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.  The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0001193125-25-301000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525301000/ownership.xml","form_type":"4"}},{"id":986747,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-11-26T20:37:25.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":true,"shares":11699,"price":64.6,"value":755755.4,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":151424,"source":{"system":"sec-edgar","filing":"0001193125-25-301000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525301000/ownership.xml","form_type":"4"}},{"id":986746,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-11-26T20:37:25.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":45.5,"value":1137500.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":139725,"source":{"system":"sec-edgar","filing":"0001193125-25-301000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525301000/ownership.xml","form_type":"4"}},{"id":1017481,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-16T20:15:00.000Z","date":"2025-10-14","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":35615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-241720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525241720/ownership.xml","form_type":"4"}},{"id":1017480,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-10-16T20:15:00.000Z","date":"2025-10-14","kind":"sale","planned":true,"acquired":false,"shares":13786,"price":69.173,"value":953618.978,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $68.89 to $69.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0001193125-25-241720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525241720/ownership.xml","form_type":"4"}},{"id":1017479,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-10-16T20:15:00.000Z","date":"2025-10-14","kind":"sale","planned":true,"acquired":false,"shares":11214,"price":68.5057,"value":768222.9198,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $67.83 to $68.81, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":128511,"source":{"system":"sec-edgar","filing":"0001193125-25-241720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525241720/ownership.xml","form_type":"4"}},{"id":1017478,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-10-16T20:15:00.000Z","date":"2025-10-14","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":45.5,"value":1137500.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":139725,"source":{"system":"sec-edgar","filing":"0001193125-25-241720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525241720/ownership.xml","form_type":"4"}},{"id":1036189,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-18T17:23:33.000Z","date":"2025-09-16","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":60615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-207589","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525207589/ownership.xml","form_type":"4"}},{"id":1036188,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-09-18T17:23:33.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":71.6596,"value":1791490.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $71.285 to $71.88, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0001193125-25-207589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525207589/ownership.xml","form_type":"4"}},{"id":1036187,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-09-18T17:23:33.000Z","date":"2025-09-16","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":45.5,"value":1137500.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":139725,"source":{"system":"sec-edgar","filing":"0001193125-25-207589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000119312525207589/ownership.xml","form_type":"4"}},{"id":1066249,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-14T17:01:23.000Z","date":"2025-08-12","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":85615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-109039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025109039/ownership.xml","form_type":"4"}},{"id":1066248,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-08-14T17:01:23.000Z","date":"2025-08-12","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":72.3131,"value":1807827.5,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $71.63 to $72.59, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0000950170-25-109039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025109039/ownership.xml","form_type":"4"}},{"id":1066247,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-08-14T17:01:23.000Z","date":"2025-08-12","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":45.5,"value":1137500.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":139725,"source":{"system":"sec-edgar","filing":"0000950170-25-109039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025109039/ownership.xml","form_type":"4"}},{"id":1085366,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-16","kind":"exercise","planned":true,"acquired":false,"shares":2491,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":35451,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":2491},"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085365,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-15","kind":"exercise","planned":true,"acquired":false,"shares":14875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":37942,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":14875},"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085364,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":110615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085363,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-16","kind":"sale","planned":true,"acquired":false,"shares":2491,"price":75,"value":186825.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085362,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-16","kind":"exercise","planned":true,"acquired":true,"shares":2491,"price":64.6,"value":160918.6,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":117216,"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085361,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-15","kind":"sale","planned":true,"acquired":false,"shares":280,"price":75.3032,"value":21084.896,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $75.30 to $75.305, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085360,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-15","kind":"sale","planned":true,"acquired":false,"shares":39595,"price":74.8126,"value":2962204.897,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $74.30 to $75.245, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":115005,"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085359,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-15","kind":"exercise","planned":true,"acquired":true,"shares":14875,"price":64.6,"value":960925.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":154600,"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1085358,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-07-17T20:16:40.000Z","date":"2025-07-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":45.5,"value":1137500.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":139725,"source":{"system":"sec-edgar","filing":"0000950170-25-096726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025096726/ownership.xml","form_type":"4"}},{"id":1100932,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T20:06:20.000Z","date":"2025-06-24","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":135615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-090574","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025090574/ownership.xml","form_type":"4"}},{"id":1100931,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-26T20:06:20.000Z","date":"2025-06-24","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":74.0212,"value":1850530.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $73.34 to $74.33, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0000950170-25-090574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025090574/ownership.xml","form_type":"4"}},{"id":1100930,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-26T20:06:20.000Z","date":"2025-06-24","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":45.5,"value":1137500.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":139725,"source":{"system":"sec-edgar","filing":"0000950170-25-090574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025090574/ownership.xml","form_type":"4"}},{"id":1113067,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-12T20:35:59.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":false,"shares":8683,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":52817,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":8683},"source":{"system":"sec-edgar","filing":"0000950170-25-085748","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025085748/ownership.xml","form_type":"4"}},{"id":1113066,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-12T20:35:59.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":160615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-085748","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025085748/ownership.xml","form_type":"4"}},{"id":1113065,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:35:59.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":179,"price":76.57,"value":13706.03,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114725,"source":{"system":"sec-edgar","filing":"0000950170-25-085748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025085748/ownership.xml","form_type":"4"}},{"id":1113064,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:35:59.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":33504,"price":76.223,"value":2553775.392,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $75.555 to $76.50, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":114904,"source":{"system":"sec-edgar","filing":"0000950170-25-085748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025085748/ownership.xml","form_type":"4"}},{"id":1113063,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:35:59.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":true,"shares":8683,"price":64.6,"value":560921.8,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":148408,"source":{"system":"sec-edgar","filing":"0000950170-25-085748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025085748/ownership.xml","form_type":"4"}},{"id":1113062,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:35:59.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":45.5,"value":1137500.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":139725,"source":{"system":"sec-edgar","filing":"0000950170-25-085748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025085748/ownership.xml","form_type":"4"}},{"id":1238179,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-28T16:04:04.000Z","date":"2025-02-27","kind":"gift","planned":false,"acquired":true,"shares":95671,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective February 27, 2025, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 95,671 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":95671,"derivative":{"exercise_price":77.91,"expiration_date":"2034-12-16","underlying":"Class A Common Stock","underlying_shares":95671},"source":{"system":"sec-edgar","filing":"0000950170-25-029982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025029982/ownership.xml","form_type":"4"}},{"id":1238178,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-28T16:04:04.000Z","date":"2025-02-27","kind":"gift","planned":false,"acquired":false,"shares":95671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective February 27, 2025, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 95,671 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":95671,"derivative":{"exercise_price":77.91,"expiration_date":"2034-12-16","underlying":"Class A Common Stock","underlying_shares":95671},"source":{"system":"sec-edgar","filing":"0000950170-25-029982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017025029982/ownership.xml","form_type":"4"}},{"id":1326409,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-18T21:19:35.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":15477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,993 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 15,477 PSUs. The remaining 6,516 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,993 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 15,477 PSUs. The remaining 6,516 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":15477},"source":{"system":"sec-edgar","filing":"0000950170-24-138156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024138156/ownership.xml","form_type":"4"}},{"id":1326408,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-18T21:19:35.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":95671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted for a total of 95,671 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":95671,"derivative":{"exercise_price":77.91,"expiration_date":"2034-12-16","underlying":"Class A Common Stock","underlying_shares":95671},"source":{"system":"sec-edgar","filing":"0000950170-24-138156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024138156/ownership.xml","form_type":"4"}},{"id":1326407,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-18T21:19:35.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":27212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":27212,"derivative":{"underlying":"Class A Common Stock","underlying_shares":27212},"source":{"system":"sec-edgar","filing":"0000950170-24-138156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024138156/ownership.xml","form_type":"4"}},{"id":1326406,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:19:35.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":31483,"price":79.18,"value":2492823.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transaction (i) include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 23,325 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units."}],"balance_after":127735,"source":{"system":"sec-edgar","filing":"0000950170-24-138156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024138156/ownership.xml","form_type":"4"}},{"id":1326405,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:19:35.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":15477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions (i) include 174,745 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 7,679 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of performance-based restricted stock units."}],"balance_after":182543,"source":{"system":"sec-edgar","filing":"0000950170-24-138156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024138156/ownership.xml","form_type":"4"}},{"id":1326404,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:19:35.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":54425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 54,425 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 174,745 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":174745,"source":{"system":"sec-edgar","filing":"0000950170-24-138156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024138156/ownership.xml","form_type":"4"}},{"id":1349078,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-27T17:44:30.000Z","date":"2024-11-26","kind":"exercise","planned":true,"acquired":false,"shares":7888,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":0,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":7888},"source":{"system":"sec-edgar","filing":"0000950170-24-131633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024131633/ownership.xml","form_type":"4"}},{"id":1349077,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-27T17:44:30.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":7888,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-131633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024131633/ownership.xml","form_type":"4"}},{"id":1349076,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-11-27T17:44:30.000Z","date":"2024-11-26","kind":"sale","planned":true,"acquired":false,"shares":7888,"price":80.19,"value":632538.72,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":83721,"source":{"system":"sec-edgar","filing":"0000950170-24-131633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024131633/ownership.xml","form_type":"4"}},{"id":1349075,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-11-27T17:44:30.000Z","date":"2024-11-26","kind":"exercise","planned":true,"acquired":true,"shares":7888,"price":62.32,"value":491580.16,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":91609,"source":{"system":"sec-edgar","filing":"0000950170-24-131633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024131633/ownership.xml","form_type":"4"}},{"id":1349074,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-11-27T17:44:30.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":896,"price":81.1764,"value":72734.0544,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $81.135 to $81.215, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":83721,"source":{"system":"sec-edgar","filing":"0000950170-24-131633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024131633/ownership.xml","form_type":"4"}},{"id":1349073,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-11-27T17:44:30.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":49104,"price":80.5277,"value":3954232.1808,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $80.125 to $81.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":84617,"source":{"system":"sec-edgar","filing":"0000950170-24-131633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024131633/ownership.xml","form_type":"4"}},{"id":1349072,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-11-27T17:44:30.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":62.32,"value":3116000.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":133721,"source":{"system":"sec-edgar","filing":"0000950170-24-131633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024131633/ownership.xml","form_type":"4"}},{"id":1384628,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-10-17T17:14:46.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":false,"shares":28512,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":57888,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":28512},"source":{"system":"sec-edgar","filing":"0000950170-24-115380","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024115380/ownership.xml","form_type":"4"}},{"id":1384627,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-10-17T17:14:46.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":9816,"price":74.5467,"value":731750.4072,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $74.38 to $74.74, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":83721,"source":{"system":"sec-edgar","filing":"0000950170-24-115380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024115380/ownership.xml","form_type":"4"}},{"id":1384626,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-10-17T17:14:46.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":18696,"price":73.8999,"value":1381632.5304,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $73.38 to $74.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":93537,"source":{"system":"sec-edgar","filing":"0000950170-24-115380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024115380/ownership.xml","form_type":"4"}},{"id":1384625,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-10-17T17:14:46.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":true,"shares":28512,"price":62.32,"value":1776867.84,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 reported in the Form 4 filed for the Reporting Person on June 25, 2024 were incorrectly reported as 83,271.  The correct amount was 83,721 at that time, and the shares held reported herein reflect the corrected amount."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":112233,"source":{"system":"sec-edgar","filing":"0000950170-24-115380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024115380/ownership.xml","form_type":"4"}},{"id":1469391,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-06-25T21:28:41.000Z","date":"2024-06-17","kind":"purchase","planned":false,"acquired":true,"shares":2.5592,"price":78.15,"value":200.00148,"ownership":{"direct":false,"nature":"By a son"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This indirect purchase by a family member of the reporting person occurred without the reporting person's knowledge and is being reported within two business days of the reporting person being made aware of the transaction.  The indirect purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 2.5592 shares, with a sale by the reporting person of DLB Class A common stock at a maximum price of $83.92 per share on January 17, 2024. The reporting person has paid to the Issuer $14.77, representing the full amount of the profit imputed to the reporting person in connection with the matching transactions."}],"balance_after":2.5592,"source":{"system":"sec-edgar","filing":"0000950170-24-077565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024077565/ownership.xml","form_type":"4"}},{"id":1642784,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-14T16:22:46.000Z","date":"2024-02-12","kind":"gift","planned":false,"acquired":true,"shares":81884,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective February 12, 2024, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 81,884 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":81884,"derivative":{"exercise_price":87.49,"expiration_date":"2033-12-15","underlying":"Class A Common Stock","underlying_shares":81884},"source":{"system":"sec-edgar","filing":"0000950170-24-015250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024015250/ownership.xml","form_type":"4"}},{"id":1642783,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-14T16:22:46.000Z","date":"2024-02-12","kind":"gift","planned":false,"acquired":false,"shares":81884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective February 12, 2024, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 81,884 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":81884,"derivative":{"exercise_price":87.49,"expiration_date":"2033-12-15","underlying":"Class A Common Stock","underlying_shares":81884},"source":{"system":"sec-edgar","filing":"0000950170-24-015250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024015250/ownership.xml","form_type":"4"}},{"id":1675049,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-19T16:24:06.000Z","date":"2024-01-17","kind":"exercise","planned":false,"acquired":false,"shares":8784,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":185615,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":8784},"source":{"system":"sec-edgar","filing":"0000950170-24-005798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024005798/ownership.xml","form_type":"4"}},{"id":1675048,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-19T16:24:06.000Z","date":"2024-01-17","kind":"exercise","planned":false,"acquired":false,"shares":246,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":0,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":246},"source":{"system":"sec-edgar","filing":"0000950170-24-005798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024005798/ownership.xml","form_type":"4"}},{"id":1675047,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-01-19T16:24:06.000Z","date":"2024-01-17","kind":"sale","planned":false,"acquired":false,"shares":9030,"price":83.5086,"value":754082.658,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $83.34 to $83.92, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":83721,"source":{"system":"sec-edgar","filing":"0000950170-24-005798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024005798/ownership.xml","form_type":"4"}},{"id":1675046,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-01-19T16:24:06.000Z","date":"2024-01-17","kind":"exercise","planned":false,"acquired":true,"shares":8784,"price":45.5,"value":399672.0,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":92751,"source":{"system":"sec-edgar","filing":"0000950170-24-005798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024005798/ownership.xml","form_type":"4"}},{"id":1675045,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2024-01-19T16:24:06.000Z","date":"2024-01-17","kind":"exercise","planned":false,"acquired":true,"shares":246,"price":42.98,"value":10573.08,"ownership":{"direct":false,"nature":"By a trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"}],"balance_after":83967,"source":{"system":"sec-edgar","filing":"0000950170-24-005798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000095017024005798/ownership.xml","form_type":"4"}},{"id":1704541,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-19T19:35:47.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":17202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,394 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 17,202 PSUs. The remaining 4,192 PSUs were cancelled.  The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,394 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 17,202 PSUs. The remaining 4,192 PSUs were cancelled.  The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":17202},"source":{"system":"sec-edgar","filing":"0001209191-23-059262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123059262/doc4.xml","form_type":"4"}},{"id":1704540,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-19T19:35:47.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":81884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option was granted for a total of 81,884 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":81884,"derivative":{"exercise_price":87.49,"expiration_date":"2033-12-15","underlying":"Class A Common Stock","underlying_shares":81884},"source":{"system":"sec-edgar","filing":"0001209191-23-059262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123059262/doc4.xml","form_type":"4"}},{"id":1704539,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-19T19:35:47.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":23359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"kind","element":"transactionCoding","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":23359,"derivative":{"underlying":"Class A Common Stock","underlying_shares":23359},"source":{"system":"sec-edgar","filing":"0001209191-23-059262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123059262/doc4.xml","form_type":"4"}},{"id":1704538,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:35:47.000Z","date":"2023-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":5268,"price":87.49,"value":460897.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held following reported transactions (i) include 120,320 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 5,357 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units."}],"balance_after":120320,"source":{"system":"sec-edgar","filing":"0001209191-23-059262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123059262/doc4.xml","form_type":"4"}},{"id":1704537,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:35:47.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":26047,"price":88.6,"value":2307764.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transaction (i) include 130,945 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 17,812 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units."}],"balance_after":130945,"source":{"system":"sec-edgar","filing":"0001209191-23-059262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123059262/doc4.xml","form_type":"4"}},{"id":1704536,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:35:47.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":17202,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions (i) include 166,275 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 8,673 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of performance-based restricted stock units."}],"balance_after":174804,"source":{"system":"sec-edgar","filing":"0001209191-23-059262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123059262/doc4.xml","form_type":"4"}},{"id":1704535,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:35:47.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":46718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 46,718 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 166,275 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":166275,"source":{"system":"sec-edgar","filing":"0001209191-23-059262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123059262/doc4.xml","form_type":"4"}},{"id":1710777,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-14T17:58:25.000Z","date":"2023-12-12","kind":"exercise","planned":false,"acquired":false,"shares":18060,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":246,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":18060},"source":{"system":"sec-edgar","filing":"0001209191-23-058686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123058686/doc4.xml","form_type":"4"}},{"id":1710776,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-12-14T17:58:25.000Z","date":"2023-12-12","kind":"sale","planned":false,"acquired":false,"shares":18060,"price":89.1714,"value":1610435.484,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $88.96 to $89.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":51879,"source":{"system":"sec-edgar","filing":"0001209191-23-058686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123058686/doc4.xml","form_type":"4"}},{"id":1710775,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-12-14T17:58:25.000Z","date":"2023-12-12","kind":"exercise","planned":false,"acquired":true,"shares":18060,"price":42.98,"value":776218.8,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"balance_after":69939,"source":{"system":"sec-edgar","filing":"0001209191-23-058686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123058686/doc4.xml","form_type":"4"}},{"id":1730164,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-11-24T16:58:45.000Z","date":"2023-11-21","kind":"exercise","planned":false,"acquired":false,"shares":45150,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":18306,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":45150},"source":{"system":"sec-edgar","filing":"0001209191-23-056594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123056594/doc4.xml","form_type":"4"}},{"id":1730163,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-11-24T16:58:45.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":36120,"price":85,"value":3070200.0,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"balance_after":51879,"source":{"system":"sec-edgar","filing":"0001209191-23-056594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123056594/doc4.xml","form_type":"4"}},{"id":1730162,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-11-24T16:58:45.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":9030,"price":83.9843,"value":758378.229,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $83.45 to $84.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":87999,"source":{"system":"sec-edgar","filing":"0001209191-23-056594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123056594/doc4.xml","form_type":"4"}},{"id":1730161,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-11-24T16:58:45.000Z","date":"2023-11-21","kind":"exercise","planned":false,"acquired":true,"shares":45150,"price":42.98,"value":1940547.0,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"balance_after":97029,"source":{"system":"sec-edgar","filing":"0001209191-23-056594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123056594/doc4.xml","form_type":"4"}},{"id":1757398,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-10-19T17:17:08.000Z","date":"2023-10-17","kind":"exercise","planned":false,"acquired":false,"shares":9030,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":63456,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":9030},"source":{"system":"sec-edgar","filing":"0001209191-23-053191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123053191/doc4.xml","form_type":"4"}},{"id":1757397,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-10-19T17:17:08.000Z","date":"2023-10-17","kind":"sale","planned":false,"acquired":false,"shares":300,"price":82.8867,"value":24866.01,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $82.88 to $82.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":51879,"source":{"system":"sec-edgar","filing":"0001209191-23-053191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123053191/doc4.xml","form_type":"4"}},{"id":1757396,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-10-19T17:17:08.000Z","date":"2023-10-17","kind":"sale","planned":false,"acquired":false,"shares":7054,"price":82.4852,"value":581850.6008,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $81.88 to $82.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":52179,"source":{"system":"sec-edgar","filing":"0001209191-23-053191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123053191/doc4.xml","form_type":"4"}},{"id":1757395,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-10-19T17:17:08.000Z","date":"2023-10-17","kind":"sale","planned":false,"acquired":false,"shares":1676,"price":81.5287,"value":136642.1012,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $80.805 to $81.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":59233,"source":{"system":"sec-edgar","filing":"0001209191-23-053191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123053191/doc4.xml","form_type":"4"}},{"id":1757394,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-10-19T17:17:08.000Z","date":"2023-10-17","kind":"exercise","planned":false,"acquired":true,"shares":9030,"price":42.98,"value":388109.4,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"balance_after":60909,"source":{"system":"sec-edgar","filing":"0001209191-23-053191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123053191/doc4.xml","form_type":"4"}},{"id":1780882,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":67199,"kind":"person","name":"YEAMAN KEVIN J","position":1,"cik":"0001200469","reported_name":"YEAMAN KEVIN J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-09-14T19:41:01.000Z","date":"2023-09-12","kind":"exercise","planned":false,"acquired":false,"shares":18060,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":72486,"derivative":{"exercise_price":42.98,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":18060},"source":{"system":"sec-edgar","filing":"0001209191-23-049516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1200469/000120919123049516/doc4.xml","form_type":"4"}}],"next_cursor":"2023-09-14T19:41:01.000000Z,1780882"}